Prevalencia del sub-diagnóstico de síndrome metabólico en pacientes con síndrome coronario agudo, entre los 40 y 90 años de edad, en la Clínica Centro S.A. Barranquilla, durante el periodo de enero a mayo de 2020
Fecha
2020
Autores
Charris Charris, Silvya
Espinosa Diaz, Clarena
Vásquez Picón, Stiven
Título de la revista
ISSN de la revista
Título del volumen
Editor
Ediciones Universidad Simón Bolívar
Facultad de Ciencias de la Salud
Facultad de Ciencias de la Salud
Resumen
Introducción: El síndrome metabólico como predictor de morbi-mortalidad cardiovascular, constituido por obesidad central, dislipidemia, disminución de colesterol HDL, resistencia a la insulina e hipertensión arterial. El diagnóstico correcto y oportuno, permite prevenir complicaciones cardiovasculares como síndrome coronario agudo. Objetivo: Estimar la prevalencia del sub-diagnóstico de síndrome metabólico en pacientes con síndrome coronario agudo, entre los 40 y 90 años de edad, en la Clínica Centro S.A. Barranquilla, durante el periodo de enero a mayo de 2020. Métodos: Estudio descriptivo de corte transversal observacional, no experimental de enfoque cuantitativo. La población de estudio fue 286 pacientes valorados por el servicio de cardiología de la Clínica Centro S.A Barranquilla/Atlántico, durante el periodo de enero a mayo de 2020. Resultados: El diagnóstico de síndrome metabólico, fue nulo en la población estudiada, debido al abordaje de las variables de forma individual, razón por la cual se estimó un sub-diagnóstico de 125 pacientes equivalentes al 44%, de los cuales 90% debuto con algún evento coronario agudo, siendo más prevalente, el infarto agudo al miocardio sin elevación del segmento ST en un 75% de los casos. Conclusión: El diagnóstico de síndrome metabólico sigue siendo un desafío para el personal de salud, a pesar de los avances científicos, consensos, protocolos y guías de práctica clínica para el diagnóstico y tratamiento, este pasa desapercibido provocando un sub-diagnostico en el paciente, teniendo en cuenta el impacto que genera en la calidad de vida de los mismos, cuya principal consecuencia es la privación de un manejo integro de dicha patología.
Introduction: Metabolic syndrome as a predictor of cardiovascular morbidity and mortality, consisting of central obesity, dyslipidemia, decreased HDL cholesterol, insulin resistance, and high blood pressure. The correct and timely diagnosis allows to prevent cardiovascular complications such as acute coronary syndrome. Objective: To estimate the prevalence of metabolic syndrome sub-diagnosis in patients with acute coronary syndrome, between the ages of 40 and 90, at the Clínica Centro S.A. Barranquilla, during the period from January to May 2020. Methods: Descriptive, observational, non-experimental cross-sectional study with a quantitative approach. The study population was 286 patients assessed by the cardiology service of the Clínica Centro S.A Barranquilla / Atlántico, during the period from January to May 2020. Results: The metabolic syndrome diagnosis was null in the studied population, due to the approach of the variables individually, reason for which a sub-diagnosis of 125 patients equivalent to 44% was estimated, of which 90% debuted with some acute coronary event, being more prevalent, acute myocardial infarction without ST segment elevation in 75% of cases. Conclusion: The diagnosis of metabolic syndrome continues to be a challenge for health personnel, despite scientific advances, consensus, protocols and clinical practice guidelines for diagnosis and treatment, this goes unnoticed causing a sub-diagnosis in the patient, taking into account the impact it generates on their quality of life, the main consequence of which is the deprivation of full management of said pathology.
Introduction: Metabolic syndrome as a predictor of cardiovascular morbidity and mortality, consisting of central obesity, dyslipidemia, decreased HDL cholesterol, insulin resistance, and high blood pressure. The correct and timely diagnosis allows to prevent cardiovascular complications such as acute coronary syndrome. Objective: To estimate the prevalence of metabolic syndrome sub-diagnosis in patients with acute coronary syndrome, between the ages of 40 and 90, at the Clínica Centro S.A. Barranquilla, during the period from January to May 2020. Methods: Descriptive, observational, non-experimental cross-sectional study with a quantitative approach. The study population was 286 patients assessed by the cardiology service of the Clínica Centro S.A Barranquilla / Atlántico, during the period from January to May 2020. Results: The metabolic syndrome diagnosis was null in the studied population, due to the approach of the variables individually, reason for which a sub-diagnosis of 125 patients equivalent to 44% was estimated, of which 90% debuted with some acute coronary event, being more prevalent, acute myocardial infarction without ST segment elevation in 75% of cases. Conclusion: The diagnosis of metabolic syndrome continues to be a challenge for health personnel, despite scientific advances, consensus, protocols and clinical practice guidelines for diagnosis and treatment, this goes unnoticed causing a sub-diagnosis in the patient, taking into account the impact it generates on their quality of life, the main consequence of which is the deprivation of full management of said pathology.
Descripción
Palabras clave
Prevalencia, Síndrome metabólico, Síndrome coronario, Sub-diagnostico, Prevalence, Metabolic syndrome, Coronary syndrome, Sub-diagnosis
